UNSPSC 51351504: Edogestrone

This classification denotes a therapeutic progestin with the molecular formula C26H38O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9014UFK50C, chemically known as 17-hydroxy-6-methylpregn-5-ene-3,20-dione cyclic 3-(ethylene acetal) acetate but generally known as edogestrone, which bears US NIH Compound Identifier 101860. European Medicines Agency schedules Edogestrone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06459MIG. The term EDOGESTRONE is an International Non-Proprietary Name.

UNSPSC 51351504 Edogestrone is a Commodity code covering a synthetic progestational hormone used in pharmaceutical formulations. State and local governments procure edogestrone primarily through public health departments, corrections agencies, and health systems that operate clinics or pharmaceutical benefit programs serving incarcerated, low-income, or publicly insured populations. The drug is typically sourced via competitive bid or cooperative purchasing agreements established at the state level, with individual jurisdictions drawing down inventory through established state contracts or direct procurement.

The recent-opportunities block provided contains no documented state or local solicitations for edogestrone. Without visible recent RFP, RFQ, IFB, or ITB activity in the source data, the current procurement velocity for this commodity cannot be assessed, and no representative opportunities, issuing bodies, or geographic concentration can be named.